288 related articles for article (PubMed ID: 34729701)
61. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
[No Abstract] [Full Text] [Related]
62. Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability.
Liu L; Zou D; Zhang Y; Zhang Q; Feng Y; Guo Y; Liu Y; Zhang X; Cheng G; Wang C; Zhang Y; Zhang L; Wu L; Chang L; Su X; Duan Y; Zhang Y; Liu M
Eur J Pharm Biopharm; 2020 Sep; 154():62-73. PubMed ID: 32645384
[TBL] [Abstract][Full Text] [Related]
63. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
64. Cocrystals of Apixaban with Improved Solubility and Permeability: Formulation, Physicochemical Characterization, Pharmacokinetic Evaluation, and Computational Studies.
Madan JR; Waghmare SV; Patil RB; Awasthi R; Dua K
Assay Drug Dev Technol; 2021; 19(2):124-138. PubMed ID: 33601935
[No Abstract] [Full Text] [Related]
65. Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid.
Hiendrawan S; Veriansyah B; Widjojokusumo E; Soewandhi SN; Wikarsa S; Tjandrawinata RR
Int J Pharm; 2016 Jan; 497(1-2):106-13. PubMed ID: 26657269
[TBL] [Abstract][Full Text] [Related]
66. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating.
Serrano DR; Walsh D; O'Connell P; Mugheirbi NA; Worku ZA; Bolas-Fernandez F; Galiana C; Dea-Ayuela MA; Healy AM
Eur J Pharm Biopharm; 2018 Mar; 124():13-27. PubMed ID: 29196273
[TBL] [Abstract][Full Text] [Related]
67. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
Sathisaran I; Dalvi SV
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
[TBL] [Abstract][Full Text] [Related]
68. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
Kumar S; Gupta A; Mishra CK; Singh S
Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
[TBL] [Abstract][Full Text] [Related]
69. Improved Solubility and Oral Absorption of Emodin-Nicotinamide Cocrystal Over Emodin with PVP as a Solubility Enhancer and Crystallization Inhibitor.
Ban E; An SH; Park B; Park M; Yoon NE; Jung BH; Kim A
J Pharm Sci; 2020 Dec; 109(12):3660-3667. PubMed ID: 32987091
[TBL] [Abstract][Full Text] [Related]
70. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
Zeng QZ; Ouyang J; Zhang S; Zhang L
Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
[TBL] [Abstract][Full Text] [Related]
71. Novel pharmaceutical cocrystal of lenalidomide with nicotinamide: Structural design, evaluation, and thermal phase transition study.
Wang L; Yan Y; Zhang X; Zhou X
Int J Pharm; 2022 Feb; 613():121394. PubMed ID: 34933081
[TBL] [Abstract][Full Text] [Related]
72. Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects.
Cui W; He Z; Zhang Y; Fan Q; Feng N
AAPS PharmSciTech; 2019 Feb; 20(3):115. PubMed ID: 30771018
[TBL] [Abstract][Full Text] [Related]
73. Synchronization of Cocrystal Dissolution and Drug Precipitation to Sustain Drug Supersaturation.
Cogo Machado T; Kavanagh ON; Gonçalves Cardoso S; Rodríguez-Hornedo N
Mol Pharm; 2022 Aug; 19(8):2765-2775. PubMed ID: 35833828
[TBL] [Abstract][Full Text] [Related]
74. Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.
Huang Y; Kuminek G; Roy L; Cavanagh KL; Yin Q; Rodríguez-Hornedo N
Mol Pharm; 2019 Sep; 16(9):3887-3895. PubMed ID: 31318567
[TBL] [Abstract][Full Text] [Related]
75. Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion.
Li P; Yu HZ; Zhang XX; Gan L; Zhu CL; Gan Y
Acta Pharmacol Sin; 2010 Jul; 31(7):881-8. PubMed ID: 20562905
[TBL] [Abstract][Full Text] [Related]
76. Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug.
Devarapalli R; Indukuri A; Bollineni M; Mondal A; Reddy CM; Chennuru R
Mol Pharm; 2021 Mar; 18(3):1138-1149. PubMed ID: 33528261
[TBL] [Abstract][Full Text] [Related]
77. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.
Sanphui P; Tothadi S; Ganguly S; Desiraju GR
Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322
[TBL] [Abstract][Full Text] [Related]
78. First cocrystal of esculetin: Simultaneously optimized in vitro/vivo properties and antioxidant effect.
Liu F; Li JY; Han CB; Wang JH; Tong SY; Wang XK; Li YT; Sun WJ
Eur J Pharm Sci; 2023 Aug; 187():106469. PubMed ID: 37209999
[TBL] [Abstract][Full Text] [Related]
79. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
80. Diffusion and Flux Improvement of Drugs through Complexation.
Mannava MKC; Garai A; Nangia AK
Mol Pharm; 2023 May; 20(5):2293-2316. PubMed ID: 36974968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
